Suicide prevention strategies from medical perspective

Journal of the Korean Medical Association

Volumn 54, Issue 4, 2011, Pages 386-391

  Bae, Sang Bin ^a   Woo, Jong Min ^a,b  

^a Inje University College of Medicine   (South Korea)

^b Inje University   (South Korea)

Author keywords

Depression; Institute of medicine; Prevention; Suicide

Indexed keywords

EID: 79955600310     PISSN: 19758456     EISSN: None     Source Type: Journal    
DOI: 10.5124/jkma.2011.54.4.386     Document Type: Article

References (21)

1. World Health Organization. Suicide prevention (SUPRE). Geneva: World Health Organization; 2009.
2. Arango V, Underwood MD, Boldrini M, Tamir H, Kassir SA, Hsiung S, Chen JJ, Mann JJ. Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 2001;25:892-903.
3. The Korean Association for Suicide Prevention. The understanding and prevention of suicide. Seoul: Hakjisa; 2007
4. Lake CR, Baumer J. Academic psychiatry's responsibility for increasing the recognition of mood disorders and risk for suicide in primary care. Curr Opin Psychiatry 2010;23:157-166.
5. Centers for Disease Control and Prevention. Injury prevention & control: data & statistics (WISQARS) [Internet]. Atlanta: Centers for Disease Control and Prevention; 2005 [cited 2011 Mar 17]. Available from: http://www.cdc.gov/injury/wisqars/index.html.
6. Manalai R Woo JM, Postolache TT. Suicidality and montelukast. Expert Opin Drug Saf 2009;8:273-282.
7. Gibbons RD, Hur K, Bhaumik DK, Mann JJ. The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry 2005;62:165-172.
8. Woo JM, Postolache TT. The impact of work environment on mood disorders and suicide: evidence and implications. Int J Disabil Hum Dev 2008;7:185-200.
9. Rihmer Z. Strategies of suicide prevention: focus on health care. J Affect Disord 1996;39:83-91. (Pubitemid 26232799)
10. United Nations. Prevention of suicide: guidelines for the formulation and implementation of national strategies. New York: United Nations; 1996.
11. Storbritannien, Secretary of State for Health. Saving lives: our healthier nation. London: Stationary Office; 1999.
12. Great Britain, Department of Health. National suicide prevention strategy for England. London: Department of Health; 2002.
13. Goldsmith SK; The Committee on Pathophysiology and Prevention of Adolescent and Adult Suicide. Reducing suicide: a national imperative. Washington, DC: the National Academy Press; 2002.
14. Rotheram-Borus MJ, Piacentini J, Cantwell C, Belin TR, Song J. The 18-month impact of an emergency room intervention for adolescent female suicide attempters. J Consult Clin Psychol 2000;68:1081-1093. (Pubitemid 32038386)
15. Stanley B, Brown G, Brent DA, Wells K, Poling K, Curry J, Kennard BD, Wagner A, Cwik MF, Klomek AB, Goldstein T, Vitiello B, Barnett S, Daniel S, Hughes J. Cognitive-behavioral therapy for suicide prevention (CBT-SP): treatment model, feasibility, and acceptability. J Am Acad Child Adolesc Psychiatry 2009;48:1005-1013.
16. Brown GK, Ten Have T, Henriques GR, Xie SX, Hollander JE, Beck AT. Cognitive therapy for the prevention of suicide attempts: a randomized controlled trial. JAMA 2005:294:563-570.
17. Gibbons RD, Hur K, Brown CH, Mann JJ. Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder. Arch Gen Psychiatry 2009;66:1354-1360.
18. Meyer RE, Salzman C, Youngstrom EA, Clayton PJ, Goodwin FK, Mann JJ, Alphs LD, Broich K, Goodman WK, Greden JF, Meltzer HY Normand SL, Posner K, Shaffer D, Oquendo MA, Stanley B, Trivedi MH, Turecki G, Beasley CM Jr, Beautrais AL, Bridge JA, Brown GK, Revicki DA, Ryan ND, Sheehan DV. Suicidality and risk of suicide-definition, drug safety concerns, and a necessary target for drug development: a brief report. J Clin Psychiatry 2010;71:1040-1046.
19. Posner K, Oquendo MA, Gould M, Stanley B, Davies M. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry 2007;164:1035-1043. (Pubitemid 47121392)
20. Wojnar M, Ilgen MA, Wojnar J, McCammon RJ, Valenstein M, Brower KJ. Sleep problems and suicidality in the National Comorbidity Survey Replication. J Psychiatr Res 2009;43:526-531.
21. Hawton K, van Heeringen K. Suicide. Lancet 2009;373:1372-1381.